Instituto Nacional de Cancerología - Ciudad de México
Instituto Nacional de Cancerología - Ciudad de México
Avenida San Fernando 22, México DF
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Rodrigo Espinosa
Oscar G Arrieta
Open studies
Lung cancer
Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations - METLUNG - Instituto Nacional de Cancerologia de MexicoSee more
Alectinib Pharmacokinetic in Patients With NSCLC - Alectinib - Instituto Nacional de Cancerologia de MexicoSee more
Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC - Glutamine - Instituto Nacional de Cancerologia de MexicoSee more
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) - TROPION-Lung07 - AstraZenecaSee more
Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients - Pulmonary Rehabilitation - Instituto Nacional de Cancerologia de MexicoSee more
Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. - Nitroglycerin - Instituto Nacional de Cancerologia de MexicoSee more
Ovarian cancer
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention - TUBA-WISP-II - University Medical Center NijmegenSee more
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial - M.D. Anderson Cancer CenterSee more
Breast Cancer
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer - INAVO123 - Hoffmann-La RocheSee more
Cervical cancer
Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer - MICHELE - National Institute of CancerologíaSee more
Fallopian tube cancer
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial - M.D. Anderson Cancer CenterSee more
Lymphoma
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma - GO44145 - Hoffmann-La RocheSee more
Non-Hodgkin Lymphoma
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma - GO44145 - Hoffmann-La RocheSee more
Peritoneal cancer
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial - M.D. Anderson Cancer CenterSee more
Prostate cancer
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer - S1802 - Southwest Oncology GroupSee more
